Mark E. Robson
New England Journal of Medicine · 2002–2021
A researcher in the Science corpus: 17 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Whom Mark E. Robson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Mark E. Robson overall
Papers from Mark E. Robson's perspective
Ordered by how strongly the researchers Mark E. Robson trusts endorse each paper. Same corpus, a different order for every researcher.
- The Sybil Attack
- New Directions in Cryptography
- Pastry: Scalable, distributed object location and routing for large-scale peer-to-
- Kademlia: A Peer-to-Peer Information System Based on the XOR Metric (International Workshop on Peer-to-Peer Systems)
- Freenet: A Distributed Anonymous Information Storage and Retrieval System (Workshop on Design Issues in Anonymity and Unobservability)
- Tarzan: a peer-to-peer anonymizing network layer
- Pastry: Scalable, Decentralized Object Location, and Routing for Large-Scale Peer-to-Peer Systems (International Middleware Conference)
- Untraceable electronic mail, return addresses, and digital pseudonyms
- Crowds: anonymity for Web transactions
- A scalable content-addressable network (Conference on Applications, Technologies, Architectures, and Protocols for Computer Communication)
Their papers
- Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients (2017) — 2,983 citations
- A note on competing risks in survival data analysis (2004) — 730 citations
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. (2017) — 1,430 citations
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants (2019) — 647 citations
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers (2018) — 851 citations
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. (2021) — 1,237 citations
- Cancer therapy shapes the fitness landscape of clonal hematopoiesis (2020) — 599 citations
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group. (2020) — 1,018 citations
- OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer (2019) — 690 citations
- Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and impacts clinical outcome (2017) — 725 citations
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation (2017) — 1,569 citations
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer (2016) — 1,457 citations
- Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk (2015) — 863 citations
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. (2010) — 772 citations
- Eluding carnivores: file sharing with strong anonymity (2004) — 50 citations
- Herbivore: A Scalable and Efficient Protocol for Anonymous Communication (2003) — 219 citations
- Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. (2002) — 1,200 citations